Status of radiotherapy and concomitant chemoradiotherapy in locally advanced non‑small cell lung cancer and small cell lung cancer
05/2021
MUDr. Tereza Kohlová; doc. MUDr. Renata Soumarová, Ph.D.; Ing. Anna Negri; Ing. Šárka Šípová
Radioterapeutická a onkologická klinika 3. LF UK a FN Královské Vinohrady, Praha
SUMMARY
Radiotherapy is the basic treatment modality in lung cancer across all its stages. There is a therapeutic benefit in settings up to 77 per cent, but the worldwide use is lower, in the Czech Republic about 25 percent. The advanced radiotherapeutic techniques, such as IMRT (intensity modulated radiotherapy) and IGRT with monitoring of respiratory motion (image guided radiotherapy), enable to reduce a dose to the organs at risk (heart, contralateral lung), the risk of pneumonitis and they prolong the survival.
Key words
lung cancer, concomitant therapy, locally advanced non-small cell lung carcinoma, radiotherapy, small cell lung carcinoma, radiotherapy
The full article is only available to subscribers
Become a regular subscriber to our Oncological Review...